Patents by Inventor Wayne E. Barth

Wayne E. Barth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4234579
    Abstract: Penicillanic acid 1,1-dioxide, and esters thereof readily hydrolyzable in vivo, are useful as antibacterial agents, and also for enhancing the effectiveness of several .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria. Derivatives of penicillanic acid 1,1-dioxide having the carboxy group protected by a conventional penicillin carboxy protecting group are useful intermediates to penicillanic acid 1,1-dioxide. Penicillanic acid 1-oxides and certain esters thereof are useful chemical intermediates to penicillanic acid 1,1-dioxide and its esters.
    Type: Grant
    Filed: March 5, 1979
    Date of Patent: November 18, 1980
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4179511
    Abstract: Certain novel 6-acylamino-2,2-dimethyl-3-(5-tetrazolyl)penam derivatives, and salts thereof; their use as broad-spectrum antibacterial agents; and methods for their preparation. Their preparation comprises acylation of the novel intermediate, 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam or simple derivatives thereof, followed, in some cases, by further transformations of the 6-acylamino group or by removal of a protecting group from the 5-tetrazolyl moiety. Process for the preparation of 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam, simple derivatives thereof and intermediates therefor.
    Type: Grant
    Filed: November 1, 1978
    Date of Patent: December 18, 1979
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4143039
    Abstract: Certain novel 6-acylamino-2,2-dimethyl-3-(5-tetrazolyl)penam derivatives, and salts thereof; their use as broad-spectrum antibacterial agents; and methods for their preparation. Their preparation comprises acylation of the novel intermediate, 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam or simple derivatives thereof, followed, in some cases, by further transformations of the 6-acylamino group or by removal of a protecting group from the 5-tetrazolyl moiety. Process for the preparation of 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam, simple derivatives thereof and intermediates therefor.
    Type: Grant
    Filed: April 12, 1977
    Date of Patent: March 6, 1979
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4129732
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: April 14, 1978
    Date of Patent: December 12, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4121040
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: April 27, 1977
    Date of Patent: October 17, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4115385
    Abstract: Certain novel 6-acylamino-2,2-dimethyl-3-(5-tetrazolyl)penam derivatives, and salts thereof; their use as broad-spectrum antibacterial agents; and methods for their preparation. Their preparation comprises acylation of the novel intermediate, 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam or simple derivatives thereof, followed, in some cases, by further transformations of the 6-acylamino group or by removal of a protecting group from the 5-tetrazolyl moiety. Process for the preparation of 6-amino-2,2-dimethyl-3-(5-tetrazolyl)penam, simple derivatives thereof and intermediates therefor.
    Type: Grant
    Filed: April 12, 1977
    Date of Patent: September 19, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4113942
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: April 27, 1977
    Date of Patent: September 12, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4109083
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: April 27, 1977
    Date of Patent: August 22, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4109085
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: April 27, 1977
    Date of Patent: August 22, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4066657
    Abstract: The present invention discloses novel 6-acylamino-2,2-dimethyl-3-phosphonopenams and certain lower alkyl esters thereof possessing antibacterial activity, methods for their production, and intermediates therefor; the production comprises the steps of reacting 6-triphenylmethylamino-2,2-dimethylpenam-3-carboxylic acid with lead tetraacetate to form the corresponding 3-acetoxy compound, the latter is converted to .alpha.-triphenylmethylamino-5,5-dimethyl-3-thiazoline-2-acetic acid which is condensed with dimethyl phosphite to produce .alpha.-triphenylmethylamino-5,5-dimethyl-4(0,0-dimethylphosphono)-thiazol idine-2-acetic acid which is cyclized to 6-triphenylmethylamino-2,2-dimethyl-3-(0,0-dimethylphosphono)penam and the latter is subsequently deblocked and acylated.
    Type: Grant
    Filed: October 29, 1976
    Date of Patent: January 3, 1978
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4045437
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: November 8, 1976
    Date of Patent: August 30, 1977
    Assignee: Pfizer, Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4045436
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA. .sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: August 30, 1977
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4039533
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: August 2, 1977
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4039532
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: August 2, 1977
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4036846
    Abstract: The present invention discloses novel 6-acylamino-2,2-dimethyl-3-phosphonopenams and certain lower alkyl esters thereof possessing antibacterial activity, methods for their production, and intermediates therefor; the production comprises the steps of reacting 6-triphenylmethylamino-2,2-dimethylpenam-3-carboxylic acid with lead tetraacetate to form the corresponding 3-acetoxy compound, the latter is converted to .alpha.-triphenylmethylamino-5,5-dimethyl-3-thiazoline-2-acetic acid which is condensed with dimethyl phosphite to produce .alpha.-triphenylmethylamino-5,5-dimethyl-4(0,0-dimethylphosphono)-thiazol idine-2-acetic acid which is cyclized to 6-triphenylmethylamino-2,2-dimethyl-3-(0,0-dimethylphosphono)penam and the latter is subsequently deblocked and acylated.
    Type: Grant
    Filed: October 29, 1976
    Date of Patent: July 19, 1977
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4031077
    Abstract: The present invention discloses novel 6-acylamino-2,2-dimethyl-3-phosphonopenams and certain lower alkyl esters thereof possessing antibacterial activity, methods for their production, and intermediates therefor; the production comprises the steps of reacting 6-triphenylmethylamino-2,2-dimethylpenam-3-carboxylic acid with lead tetraacetate to form the corresponding 3-acetoxy compound, the latter is converted to .alpha.-triphenylmethylamino-5,5-dimethyl-3-thiazoline-2-acetic acid which is condensed with dimethyl phosphite to produce .alpha.-triphenylmethylamino-5,5-dimethyl-4(0,0-dimethylphosphono)-thiazol idine-2-acetic acid which is cyclized to 6-triphenylmethylamino-2,2-dimethyl-3-(0,0-dimethylphosphono)penam and the latter is subsequently deblocked and acylated.
    Type: Grant
    Filed: April 26, 1976
    Date of Patent: June 21, 1977
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 4026881
    Abstract: 6-(D-2-[4-Hydroxy-1,5-naphthyridine-3-carboxamido]-2-[4-hydroxyphenyl]aceta mido-2,2-dimethyl-3-(5-tetrazolyl)penam and the salts thereof are valuable antibacterial agents, particularly for the control of bacterial infections in mammals, especially man.
    Type: Grant
    Filed: April 16, 1976
    Date of Patent: May 31, 1977
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 3998883
    Abstract: A novel process is described for the preparation of 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide, a key intermediate in the synthesis of the known useful psychotherapeutic agents: chlorodiazepoxide and diazepam. This intermediate is prepared by the cyclization of 2-(1'-chloroimino-2'-chloromethyl)-5-chlorobenzophenone, itself a new compound. This compound in turn is prepared by the chloroacetylation of 2-amino-5-chlorobenzophenone to 2-chloroacetamido-5-chlorobenzophenone, another novel compound, and subsequent iminochloride formation.
    Type: Grant
    Filed: October 28, 1975
    Date of Patent: December 21, 1976
    Assignee: Pfizer Inc.
    Inventors: Susumu Nakanishi, Wayne E. Barth
  • Patent number: 3992388
    Abstract: Disclosed herein is an improved process for the preparation of known hypoglycemic piperidinesulfamylureas of the structue ##SPC1##Wherein R is selected from the group consisting of 3-(2-methoxy)pyridyl, 3-(2-ethoxy)pyridyl and 2-(4-chloro)pyridyl and R' is selected from the group consisting of bicyclo[2.2.1]hept-5-en-2-yl-endo-methyl, bicyclo[2.2.1]hept-2-yl-endo-methyl, 7-oxabicyclo[2.2.1]hept-2-yl-methyl, 1-adamantyl and cycloalkyl having from five to eight carbon atoms.Said process comprises contacting 4-(2-pyridyl-amidoethyl) piperidine of the structue ##SPC2##With substantially one equivalent of sulfamide thereby exclusively sulfonating the piperidine nitrogen atom.
    Type: Grant
    Filed: October 17, 1975
    Date of Patent: November 16, 1976
    Assignee: Pfizer Inc.
    Inventors: Wayne E. Barth, Donald E. Kuhla
  • Patent number: 3968213
    Abstract: 5-Carboxypyrimidine derivatives and their pharmaceutically acceptable basic salts, and their use as antiallergy agents.
    Type: Grant
    Filed: January 14, 1975
    Date of Patent: July 6, 1976
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth